Stock · NSE
ALKEM
5,368.00▼ 81.50 (-1.50%)Last 2 days · 15m candles25/8/2026, 01:23:17
Open: 5,429.50High: 5,449.50Low: 5,239.50Prev: 5,449.50
VERIFIEDMint Markets·13d★ ON YOUR LIST
Four midcap stocks near 52-week highs that still look cheapAI summary· NEUTRAL
- ·AU Small Finance Bank, Lloyds Metals, Sona Comstar, and Alkem are trading near their 52-week highs.
- ·Earnings growth has helped to keep the valuations of these stocks in check.
- ·The article identifies these four midcap stocks as potentially undervalued despite their proximity to yearly peaks.
VERIFIEDMint Markets·24d★ ON YOUR LIST
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 31 July 2026AI summary· NEUTRAL
- ·Motilal Oswal recommends three stocks for purchase: Sona BLW Precision, Alkem Laboratories, and RBL Bank.
- ·The Indian stock market is anticipated to open flat-to-positive, influenced by global market trends.
- ·Nifty 50 and Sensex experienced gains in the preceding trading session.
VERIFIEDMint Markets·35d★ ON YOUR LIST
Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal StreetAI summary· POSITIVE
- ·Torrent Pharmaceuticals and Mankind Pharma saw gains exceeding 3% on the Nifty Pharma index.
- ·Cipla, Divi’s Laboratories, Laurus Labs, Alkem Laboratories, and Sai Life Sciences shares increased by over 2%.
- ·The pharma stocks experienced a rise despite weak trends observed on the Dalal Street.
VERIFIEDET Finance·62d★ ON YOUR LIST
Indian pharma firms gear up to supply key cancer drug to USAI summary· NEUTRAL
- ·Indian drugmakers are preparing to supply ifosfamide injection to the US.
- ·Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to provide the chemotherapy drug.
- ·The US FDA has contacted Indian pharmaceutical bodies to find manufacturers for the drug.
VERIFIEDMint Markets·77d★ ON YOUR LIST
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a rowVERIFIEDET Markets·82d★ ON YOUR LIST
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealAI summary· NEUTRAL
- ·Block deals worth Rs 930 crore involving 17.88 lakh Alkem Laboratories shares occurred at Rs 5,200 each.
- ·Promoter-linked entities sold their stake, while domestic mutual funds and foreign institutional investors bought shares.
- ·Alkem Laboratories launched semaglutide pre-filled syringes in India.
VERIFIEDET Stocks·83d★ ON YOUR LIST
Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani PortsAI summary· NEUTRAL
- ·Nifty showed signs of recovery but faced resistance around 23,800-24,000.
- ·Alkem Labs, Vedanta, Canara Bank, NHPC, and Adani Ports are in focus due to corporate developments.
- ·Developments include block deals, ED visits, capital raising, oversubscribed OFS, and strong cargo volumes.
VERIFIEDET Markets·83d★ ON YOUR LIST
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyersAI summary· NEUTRAL
- ·Alkem Laboratories saw block deals worth Rs 930 crore.
- ·Promoter family entities sold shares to domestic mutual funds and foreign institutional investors.
- ·The transaction follows a strong performance by Alkem Laboratories shares in the past year.
VERIFIEDET Stocks·83d★ ON YOUR LIST
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyersAI summary· NEUTRAL
- ·Alkem Laboratories saw block deals worth Rs 930 crore.
- ·Promoter family entities sold shares to domestic mutual funds and foreign institutional investors.
- ·The transaction follows a strong performance by Alkem Laboratories shares in the past year.
VERIFIEDET Finance·83d★ ON YOUR LIST
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAI summary· NEUTRAL
- ·Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India.
- ·The product is priced at Rs 350 and is intended for diabetes and weight loss management.
- ·Alkem is the first company in India to offer semaglutide in this pre-filled syringe format.
Google News, NIFTY/SENSEX·83d★ ON YOUR LIST
Sensex Today | Stock Market Live: Sensex, Nifty down at pre-open; Hero Moto, Alkem Labs, NHPC, Equitas SFB in focus - Moneycontrol.comGoogle News, NIFTY/SENSEX·83d★ ON YOUR LIST
Sensex Today | Stock Market LIVE Updates: Alkem Labs sees shares worth ₹930 crore change hands in large trade - CNBC TV18Google News, India stocks·83d★ ON YOUR LIST
Sensex Today | Stock Market Live: GIFT Nifty signals a negative opening; Hero Moto, Alkem Labs, NHPC, Equitas SFB in focus - Moneycontrol.com